Business Context and Reporting Period
Company: Plexus Corp.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended December 31, 1999
Business Overview: Plexus is a contract service provider offering design, manufacturing, and testing services to the electronics industry, primarily serving medical, computer, industrial, networking, telecommunications, and transportation sectors. The company operates largely on a "turnkey" basis, procuring materials and managing inventory risk for customers.
Key Financial Metrics
| Metric | Q4 1999 | Q4 1998 |
|---|---|---|
| Net Sales | $147,094,000 | $120,585,000 |
| Gross Profit | $20,549,000 | $16,904,000 |
| Gross Margin | 14.0% | 14.0% |
| Operating Income | $13,387,000 | $10,835,000 |
| Net Income | $8,254,000 | $6,825,000 |
| Diluted EPS | $0.44 | $0.37 |
| Cash Flow from Operations | ($1,307,000) | $5,994,000 |
| Cash and Equivalents (End of Period) | $25,678,000 | $29,170,000 |
| Total Debt | $149,000 | Filing text does not provide a clear comparative total debt figure for Q4 1998 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 22% year-over-year, driven by increased shipments to existing and new customers, particularly in the Networking/telecom sector (sales to Lucent Technologies increased significantly).
- Profitability: Net income rose 21% to $8.3 million. Gross margin percentage remained steady at 14.0%, despite reduced sales volumes at the SeaMED subsidiary.
- Cash Flow Shift: Operating cash flow turned negative ($1.3 million used) compared to a positive $6.0 million in the prior year. This was primarily due to increased accounts receivable and higher inventory levels as the company stocked components to mitigate supply shortages.
- Customer Concentration: Dependence on top customers increased. The top 10 customers accounted for 69% of sales in Q4 1999, up from 58% in Q4 1998. Lucent and GE accounted for 37% of total sales combined.
Guidance, Outlook, and Risks
- Outlook: Management expects Networking/telecom sales to continue growing in fiscal 2000. Capital expenditures for fiscal 2000 are estimated at approximately $25 million, funded by cash, short-term investments, and a $40 million revolving credit facility.
- Supply Chain Risks: The company faces significant risks from component shortages (specifically flash memory, tantalum capacitors, and SAW fibers) and extended lead times. As a turnkey provider, Plexus bears the risk of component price increases if unable to pass costs to customers immediately.
- Acquisition Integration: The company completed a merger with SeaMED (July 1999) and acquired assets in Chicago and Seattle. Risks include integration challenges, retention of key personnel, and aligning SeaMED's cost structure with its reduced sales volume.
- Year 2000 Compliance: The company successfully entered the Year 2000 with no mission-critical system failures. Costs were not material, though future claims or supplier failures remain a contingency risk.
- Dividends: The company does not expect to pay cash dividends in the foreseeable future, preferring to reinvest earnings for expansion.
Investor Verification Checklist
- Component Availability: Verify current status of supply chain for critical components (memory, logic devices) and potential impact on production schedules.
- Customer Concentration: Monitor order volumes from Lucent Technologies and General Electric, which represent a significant portion of revenue.
- Working Capital Trends: Track accounts receivable days and inventory turnover to ensure the cash flow drain observed in Q4 1999 is temporary and not indicative of collection issues or obsolescence.
- SeaMED Performance: Assess whether SeaMED's sales volume has stabilized or if further cost reductions are required to improve margins.
- Capital Expenditures: Confirm the $25 million capital expenditure plan for fiscal 2000 and the funding sources utilized.